Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product

PURPOSE: ABP 710 has been developed as a biosimilar to infliximab reference product (RP). The objective of this study was to assess analytical similarity (structural and functional) between ABP 710 and infliximab RP licensed by the United States Food and Drug Administration (infliximab [US]) and the...

Descripción completa

Detalles Bibliográficos
Autores principales: Saleem, Ramsey, Cantin, Greg, Wikström, Mats, Bolton, Glen, Kuhns, Scott, McBride, Helen J., Liu, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261735/
https://www.ncbi.nlm.nih.gov/pubmed/32476063
http://dx.doi.org/10.1007/s11095-020-02816-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261735/
https://www.ncbi.nlm.nih.gov/pubmed/32476063
http://dx.doi.org/10.1007/s11095-020-02816-w

Ejemplares similares